Literature DB >> 1344207

Lewy body dementia.

G Lennox1.   

Abstract

Lewy body dementia is common. It presents either with cognitive impairment and neuropsychiatric disturbance followed by parkinsonism or as dementia complicating established Parkinson's disease. It is unusual both in its pathological features and in its clinical manifestations. Although both overlap to some extent with those of Alzheimer's disease, Lewy body dementia is at least potentially recognizable during life. Some of its manifestations can be ameliorated by established methods, and it has pathological and neurochemical features which offer some hope for the development of useful palliative therapy. Major progress towards effective treatment is, however, likely to depend upon an improved understanding of the molecular mechanisms underlying its aetiology.

Entities:  

Mesh:

Year:  1992        PMID: 1344207

Source DB:  PubMed          Journal:  Baillieres Clin Neurol        ISSN: 0961-0421


  5 in total

1.  Behavioural disturbance and visual hallucinations in a 78 year old man.

Authors:  D W Schultz; G G Lennox; J W Ironside; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

2.  Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.

Authors:  T A Ala; K H Yang; J H Sung; W H Frey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

3.  Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.

Authors:  K K Gnanalingham; E J Byrne; A Thornton; M A Sambrook; P Bannister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

Review 4.  Lewy body dementia.

Authors:  J Byrne
Journal:  J R Soc Med       Date:  1997       Impact factor: 18.000

Review 5.  Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.

Authors:  Nandakumar S Narayanan; Robert L Rodnitzky; Ergun Y Uc
Journal:  Rev Neurosci       Date:  2013       Impact factor: 4.353

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.